SJ, I think we have to be extremely diplomatic re politics for a bit. Definitely a case of least said soonest mentioned and, as we saw the other day, a surprising number of OXB followers were rather keen on the other candidate.
Phil, I agree. I'm disappointed but not surprised (I had a go at reading the methodology for inclusion in the index and it's complex).
So, it really is hit and hope now for what was basically my sole target for this year - to get back in the FTSE250.
It's still possible, but I think needs OXB news to be sure of it. Pick your own odds for that.
If it happens I'll be very pleased. If we miss another quarter then end of Feb is next chance and if we get to May then we will have seen this year's results and a forecast for the profitmaking year. |
Beaten by a Raspberry Pi |
Doesn’t look like we made it |
Indeed Harry.
Hope isn’t a great investment strategy but is probably as useful as all that charting, Fibonacci, fill the gap, cup and handle nonsense that many espouse to.
Oxb story, future forecast and trend looks good and I’m hoping
Good luck all holders |
 Jasie,
The US market is delighted. The UK market I think happy for Wall St but still trying to work out what the first Labour budget did for us in the FTSE.
Reminding you of my amateur status here, I think I'm correct in saying that the yield on the 10 year gilts is now slightly higher than the number which caused the downfall of Liz Truss after her first budget. Fractions of a percentage yes but it's still big money on the size of the sums they borrow.
I'm not suggesting it will be the downfall of a Labour government, but we saw big withdrawals from the equity markets in anticipation of what RR was going to do and I've seen stories since which say the record equity withdrawals (from funds) has continued afterwards too.
Sweeping statement here but if people lose confidence in RR and see that she blew her big chance by wasting a lot of raised treasury income on doing nothing productive for the country, then they know she will be back for more soon and that will inspire nobody with confidence.
If I'm correct with any of that blunderbuss blast of a view, then we only really notice any fund selling when it crosses a percentage threshold. If there has been a lot of selling today though (in the 440k of volume), then we did very well with ready / willing takers to keep us more or less were we started the day at close.
But we have to focus on the future upside and I'm very hopeful that 415p at close today + all the other metrics they consider will have us back in the MSCI tonight.
My guess is that this will be the link and that it will come live sometime after 10pm tonight
If it does then the "MSCI UNITED KINGDOM INDEX" is around page 6 and it will list the additions for this quarter. If OXB is included again, then remember my previous point that over 800k was sold by just 3 funds when were left the same index.
I think that readmission would be a very good thing for us over the next weeks and months. Fingers crossed. |
I just wish I hadn't put $5 on A Horse called Harris! What do I know! |
Gareth
Like you I expected a better reaction from the markets this afternoon but everything seems to be very stagnant. |
A little over 400k shares traded so far today with the price all-over the place. |
Very possible Gareth, but world politics aside I think the coincidental Morgan Stanley Capital International quarterly review today is more significant for OXB shareholders short term.
As Phil mentions yesterday, sometime tonight we will know if we are back in this or not
I looked at the qualification pdf and it's nowhere as near as simple as the FTSE index (inclusion by market cap) and they take into account all kinds of things like ESG scores, so really I'm just guessing that we will get back in.
My logic? Look at that datasheet and the smallest market cap in there at the moment is £147m (so they will be getting booted out) with OXB having more than doubled our market cap to £447m since we were booted this time last year. Also I'm guessing that our ESG score will be up since Lucy was appointed.
However, OXB won't be the only company trying to get in that index at close of play today - though I am hopeful. If it happens I'll be a lot more confident about the 250 on the 22nd. If not then OXB probably need to post some news. We will see. |
Look out for a bounce for OXB at 14.30pm GMT when NYSE opens. OXB usually pick up at this time. |
135k shares in the first 30 mins? Election bounce or someone who understands the MSCI criteria? |
Don't mention the election Phil. I mentioned it once, but I think I got away with it. |
So I think the MSCI result is tomorrow, or at least around 10pm tomorrow. Also with the US election (not necessarily conclusive results) - it should be interesting I guess. |
There were quite a lot of shares traded today (c230k) after a very slow start this morning.
Needs some momentum now if we are to be back in the FTSE250 on the 22nd at close of play. It's possible - just a question of how likely.
Last Friday £551m market cap would have nudged out 325th place. OXB have roughly 106m shares so 520p per share needed in 13 trading days for that assuming the value of the index stays the same.
418p at close today so +8p per day on average might be enough. You know I have hopes that getting back into the MSCI this week will bring in the buyers to do that - but I'm not sure. |
Chart looks good to me as a novice. Could be fireworks tonight? |
The Eurovision side of this always makes me smile. Anyway, back to OXB.
OXB presented recently in Rome at the European Society of Cell & Gene Therapy 2024 conference.
You'd never guess unless you looked for it, but the relevant poster they presented is hidden on the OXB website here
Crucial part to note here for those of us interested in OXB are the terms SAN & M-SAN.
"Our findings demonstrate that the use of SAN and M-SAN exhibited superior activity under typical LV manufacturing conditions.".
SAN is Salt Active Nucleases and it's the technology of ArcticZymes where our CEO Frank is the new Chairman and I understand from today's internet trawl that OXB are the first to try it.
”M-SAN demonstrated superior performance compared to the Industry Standard Nuclease when integrated into OXB’s LV production process”
"SAN also outperformed the Industry Standard Nuclease when integrated into OXB’s LV production”
“Over 10-fold reduction in residual DNA compared to the Industry Standard Nuclease” |
Good to see a valued partner progressing Marcus, but just to clarify BEAM-201 is the CAR-T we partner them with. |
John Evans
@john_evans3
·
1h
In the liver, we have also completed dosing of the first cohort for the BEAM-302 trial for AATD, and have sites opening around the world.
Startup is progressing well for BEAM-301 in GSD1a in the US.
In a few hours we will also share the abstracts/data submitted to ASH and accepted for the conference, as well as holding a conference call at 8:30am ET where we will discuss the results |
Oh dear ..this is how religious wars start. |
I would have thought Psalm 22 was more appropriate here. |
Even though I walk through the valley of the shadow of death, I fear no evil, for You are with me; Your rod and Your staff, they comfort me.
Psalm 23
Well,well,i think a bit of scripture reading wouldn’t go amiss in the Dominic household.Thereagain,could be a reference to “into the valley of death rode the 600’.Time will tell. |
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Hot Features
Premium
